Current Concepts in the Management of Duchenne Muscular Dystrophy

被引:0
|
作者
Rinaldi R.J. [1 ]
Mayer M.P. [1 ]
Dichiaro M.R. [2 ]
机构
[1] Section of Pediatric Rehabilitation Medicine, The Children’s Mercy Hospitals and Clinics, 2401 Gillham Road, Kansas City, 64108, MO
[2] Department of Pediatric Rehabilitation Medicine, Children’s Hospital Colorado, 13123 E. 16th Street, Aurora, 80045-7106, CO
关键词
Cardiac; Duchenne muscular dystrophy; Glucocorticoids; Magnetic resonance imaging; Nutrition; Pulmonary;
D O I
10.1007/s40141-013-0011-4
中图分类号
学科分类号
摘要
The management of Duchenne muscular dystrophy (DMD) has seen dramatic change over the past two decades. Improvements in clinical monitoring of disease progression, management of cardiac and pulmonary complications, and nutritional intervention have all led to decreases in co-morbidity commonly associated with DMD, and, as a consequence, quality of life and life expectancy of individuals with DMD have both continued to improve. This review will update the reader on current trends and recent advances in the diagnosis, management, and treatment of DMD, with a focus on reviewing pertinent current literature. © 2013, Springer Science+Business Media New York.
引用
收藏
页码:65 / 71
页数:6
相关论文
共 50 条
  • [1] Current management of Duchenne muscular dystrophy in the Middle East: expert report
    Al Jumah, Mohammed
    Al Muhaizea, Mohammad
    Al Rumayyan, Ahmed
    Al Saman, Abdulaziz
    Al Shehri, Ali
    Cupler, Edward
    Jan, Mohammed
    Al Madani, Abubaker
    Fathalla, Waseem
    Kashyape, Pawan
    Kodavooru, Gururaj
    Al Thihli, Khalid
    Bastaki, Laila
    Megarbane, Andre
    Skrypnyk, Cristina
    Zamani, Gholamreza
    Tuffery-Giraud, Sylvie
    Urtizberea, Andoni
    Ortez Gonzalez, Carlos Ignacio
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (03) : 123 - 134
  • [2] Current and Emerging Therapies for Duchenne Muscular Dystrophy
    Megan Crone
    Jean K. Mah
    Current Treatment Options in Neurology, 2018, 20
  • [3] Duchenne muscular dystrophy: current cell therapies
    Sienkiewicz, Dorota
    Kulak, Wojciech
    Okurowska-Zawada, Bozena
    Paszko-Patej, Grazyna
    Kawnik, Katarzyna
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (04) : 166 - 177
  • [4] Current and Emerging Therapies for Duchenne Muscular Dystrophy
    Crone, Megan
    Mah, Jean K.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2018, 20 (08)
  • [5] Current treatment of adult Duchenne muscular dystrophy
    Wagner, Kathryn R.
    Lechtzin, Noah
    Judge, Daniel P.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2007, 1772 (02): : 229 - 237
  • [6] Current Pharmacological Strategies for Duchenne Muscular Dystrophy
    Yao, Shanshan
    Chen, Zihao
    Yu, Yuanyuan
    Zhang, Ning
    Jiang, Hewen
    Zhang, Ge
    Zhang, Zongkang
    Zhang, Baoting
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [7] Spinal management of Duchenne muscular dystrophy in children
    D'Astous, Jacques
    CURRENT ORTHOPAEDIC PRACTICE, 2012, 23 (05): : 448 - 452
  • [8] Cardiac medication management in Duchenne muscular dystrophy
    Wittekind, Samuel G.
    Villa, Chet R.
    PEDIATRIC PULMONOLOGY, 2021, 56 (04) : 747 - 752
  • [9] Current and emerging treatment strategies for Duchenne muscular dystrophy
    Mah, Jean K.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2016, 12 : 1795 - 1807
  • [10] Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy
    Iftikhar, Mohsan
    Frey, Justin
    Shohan, Md Jasimuddin
    Malek, Sohail
    Mousa, Shaker A.
    PHARMACOLOGY & THERAPEUTICS, 2021, 220